Metabolic brain abnormalities consistent with COVID-19 related encephalopathy


  • This represents the first case series linking distinct metabolic abnormalities in people with coronavirus disease 2019 (COVID-19) related encephalopathy.

Why this matters

    In people with COVID-19 showing signs of central nervous system impairment, brain 2-desoxy-2-fluoro-D-glucose (FDG) positron emission tomography computed tomography (PET/CT) should be considered.